Form 8-K - Current report:
SEC Accession No. 0001564590-20-012585
Filing Date
2020-03-24
Accepted
2020-03-24 17:24:55
Documents
13
Period of Report
2020-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20200319.htm   iXBRL 8-K 38617
2 EX-99.1 fgen-ex991_15.htm EX-99.1 328574
  Complete submission text file 0001564590-20-012585.txt   548975

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20200319.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20200319_lab.xml EX-101.LAB 18736
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20200319_pre.xml EX-101.PRE 11177
10 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20200319_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 20739300
SIC: 2834 Pharmaceutical Preparations